Litcius/Paper detail

Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study

Jim Christenson, Michael D. Hill, Richard H. Swartz, Corey Adams, Oscar Benavente, Leanne K. Casaubon, Sheldon Cheskes, Aravind Ganesh, Jonathan Dave Garman, Cameron Harris, Devin Harris, Kathy Heard, Sandra Jenneson, Yatika Kohli, Michelle Leroux, Diana Mayor, George Medvedev, Manu Mehdiratta, Laurie J. Morrison, Johanna M. Ospel, Sarah Pennington, Yaël Perez, Daniel Selchen, Alexander Stebner, John M. Tallon, Aleksander Tkach, Pieter Richard Verbeek, Michael Tymianski

2025The Lancet34 citationsDOI

Topics & Concepts

MedicinePlaceboCerebral ischaemiaAnesthesiaDouble blindRandomized controlled trialIschemiaEmergency medicineInternal medicineAlternative medicinePathologyAcute Ischemic Stroke ManagementStroke Rehabilitation and RecoveryS100 Proteins and Annexins